Childhood Cancer Survivors' Affective Response to Exercise

NCT ID: NCT05763290

Last Updated: 2025-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

125 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-22

Study Completion Date

2030-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to assess the feasibility of administering the Personalized Single-Category Implicit Association Test (PSC-IAT) to young adult survivors of childhood cancer.

Participants will perform a total of three trials of a cognitive task before and after their scheduled SJLIFE cardiovascular stress testing. Participants will then be asked to participate in a qualitative interview about the cognitive task tool and body sensations and emotions experienced during exercise.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Researchers at St. Jude Children's Research Hospital want to learn about the measurement of implicit association bias towards or against exercise in childhood cancer survivors. Additionally, researchers want to learn more about the physical and emotional experience of exercise from our survivors.

The plan for this study is to administer single category implicit association tests (PSC-IAT's) to participants during on campus SJLIFE testing and use this data to determine the feasibility of this tool's use in survivors of childhood cancer without cognitive impairment. This study will also administer the Behavioral Regulations in Exercise Questionnaire (BREQ-2)37 to participants as a construct validity check to the PSC-IAT.

The procedures include PSC-IAT and BREQ-2 tests (before and after strenuous exercise as part of the SJLIFE protocol) and a qualitative interview. These will be in addition to standard components of the SJLIFE on-campus visit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ALL, Childhood Acute Lymphoblastic Leukemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Affective Response to Exercise

Participants will perform a total of three trials of a cognitive task before and after their scheduled SJLIFE cardiovascular stress testing. Participants will then be asked to participate in a qualitative interview about the cognitive task tool and body sensations and emotions experienced during exercise.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants enrolled in St. Jude Lifetime Cohort (SJLIFE) aged 18-39 years at completion of on campus visit
* Primary diagnosis of acute lymphoblastic leukemia (ALL)
* No cranial radiation therapy (CRT) as part of treatment for ALL
* Identify as physically inactive (do not meet Centers for Disease Control and Prevention (CDC) guidelines of 150 minutes of moderate physical activity per week or 75 minutes of vigorous physical activity per week)
* Women who are not currently pregnant

Exclusion Criteria

* Individuals who cannot speak, read, and/or understand English.
* Individuals with an estimated IQ of \<70 and/or per PI discretion
* Individuals with any contraindication to stress testing (i.e. cardiovascular complications)
* Women who are currently pregnant
Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St. Jude Children's Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Megan Ware, MS, PhD

Role: PRINCIPAL_INVESTIGATOR

St. Jude Children's Research Hospital

Deo Srivastava, PhD

Role: PRINCIPAL_INVESTIGATOR

St. Jude Children's Research Hospital

Lisa Jacola, PhD, ABPP-CN2

Role: PRINCIPAL_INVESTIGATOR

St. Jude Children's Research Hospital

Rachel Webster, PhD

Role: PRINCIPAL_INVESTIGATOR

St. Jude Children's Research Hospital

Tara Brinkman, PhD

Role: PRINCIPAL_INVESTIGATOR

St. Jude Children's Research Hospital

Kevin Krull, PhD

Role: PRINCIPAL_INVESTIGATOR

St. Jude Children's Research Hospital

Melissa Hudson, MD

Role: PRINCIPAL_INVESTIGATOR

St. Jude Children's Research Hospital

Leslie Robinson, PhD

Role: PRINCIPAL_INVESTIGATOR

St. Jude Children's Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Jude Children's Research Hospital

Memphis, Tennessee, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Megan Ware, MS, PhD

Role: CONTACT

866-278-5833

Kirsten Ness, PhD

Role: CONTACT

866-278-5833

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Megan Ware, MS, PhD

Role: primary

866-278-5833

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CAREX

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.